Top Banner
1 Global Patient Safety Considerations with Pharmaceutical Product Labeling Michael R Cohen Institute for Safe Medication Practices Chairperson, International Medication Safety Network www.intmedsafe.net
39

Global Patient Safety Considerations with …€¢ Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

Mar 07, 2019

Download

Documents

buithien
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

1

Global Patient Safety Considerations

with Pharmaceutical Product

Labeling Michael R Cohen

Institute for Safe Medication PracticesChairperson, International Medication Safety Network

www.intmedsafe.net

Page 2: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

2

Some important labeling and packaging problems

Dangerous abbreviationsLook-alike labelingInconsistent and unclear expression of strengthCluttered labelingHighly stylized label graphics

Overemphasis on company name and logosLack of contrast on glass ampulsInadequate prominence of reminders and warnings

Page 3: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

3

Dangerous abbreviations and dose designations

Page 4: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

4

Page 5: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

5

New Zealand

Page 6: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...
Page 7: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

7

Look alike labeling

Page 8: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

8

Belize

Page 9: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

9

Canada

Page 10: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

10

United KingdomOral Generics

Page 11: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

11

Latin America - Colombia

Page 12: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

12

Australia

Page 13: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

13

Denmark

Page 14: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

14

Contrast on glass ampuls

Page 15: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

15

Spain

Note lack of label background – no contrast upon dark background

Page 16: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

16

Australia

Page 17: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

17

Serious medication errors with ampules of bupivacaine and tranexamic acid

• https://www.ejmanager.com/mnstemps/83/83-1444637751.pdf• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371494/• https://www.apsf.org/newsletters/html/2010/spring/02_inject.htm• https://dokumen.tips/documents/01-danger-of-wrong-drug-administration-during-

subarachnoid-blockpdfpdfcompressor.html

Ampule labeling

Page 18: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

Germany

Label position on ampuls and syringes

18

US ampul label for comparison

Page 19: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

19

Readability of information on polypropylene ampules

New Zealand

Page 20: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

Germany

Label position on ampuls and syringes

20

US ampul label for comparison

Page 21: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

21

Page 22: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

22

Expression of concentration and strength

Page 23: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

23

United States

Before and after – both are same strength

Page 24: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

24

USA

Page 25: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

25

Singapore

Page 26: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

26

New Zealand

Page 27: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

27

French label above

Spain

United Kingdom

France and French speaking African country

Greece

Spain

Page 28: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

28

Page 29: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

29

Page 30: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

30

How much heparin?

IU

Bar code?

Heparin in title is per liter while other heparin mention and electrolytes are per 500 mL

Page 31: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

31

Units not standardized to mEq or mmol

Page 32: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

32

Page 33: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

33

Page 34: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

34

Label reminders and warnings; communication of

important information

Page 35: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

Neuromuscular Blockers

35

New Zealand

Unknown Country

Page 36: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

36

Page 37: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

37

Why warning paralyzing agent on US and Canadian labels only?

Page 38: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

38

Neuromuscular Blocker look-alike New Zealand

Page 39: Global Patient Safety Considerations with …€¢  Ampule labeling Germany Label position on ampuls and syringes 18 US ampul label for comparison 19 ...

USA and Canada Neuromuscular Blocker